使用同位素标记 (CIM) 技术监测德诺苏马布治疗
Anton Eisenhauer1, Sönke Sönnichsen2, Agustina Hastuti3
1GEOMAR Helmholtz Centre for Ocean Research Kiel, Kiel, Germany; Osteolabs GmbH, Kiel, Germany.
Bone
|May 15, 2025
概括
同位素标记物 (CIM) 显示出个性化骨质疏松症治疗监测的潜力. 这项试点研究表明,CIM可能提供比DXA等传统方法更敏感的方法,用于跟踪绝经后妇女的登苏马布治疗反应.
科学领域:
- 内分泌学 在内分泌学.
- 代谢性骨疾病 代谢性骨疾病
- 生物标志物发现发现
背景情况:
- 骨质疏松症的管理依赖于双能X射线吸收计 (DXA) 和骨循环标记 (BTM) 来监测治疗疗效.
- 这些成熟的方法可能缺乏检测个性化对denosumab等疗法的反应的灵敏度.
- 测量血清和尿液中稳定的Ca同位素比率的 (Ca) 同位素标记器 (CIM) 是评估骨健康的新方法.
研究的目的:
- 评估同位素标记物 (CIM) 作为监测骨质疏松症的绝经后妇女的登苏马布治疗的敏感工具的潜力.
- 为了比较CIM的响应能力与DXA和BTM等传统标记器,以跟踪骨矿物质密度和营业额.
- 在骨质疏松症治疗期间探索CIM,副甲状腺激素 (PTH) 和Ca平衡之间的相关性.
主要方法:
- 一项涉及13名患有骨质疏松症的绝经后妇女的试点研究开始于denosumab治疗.
- 在24周内收集了CIM_血清,CIM_尿液,BMD,BTM和PTH的连续测量.
- 分析包括应用CIM值来区分净骨摄入量与排泄量,并将CIM与PTH和DXA/BTM数据相关联.
主要成果:
- 基线CIM表明骨净损失,在开始服用德诺苏马布后转向吸收,在一周内观察到显著的变化.
- CIM_血清和CIM_尿液值与PTH水平呈现出正相关性.
- 个体患者的反应有所不同,有些人快速超过CIM值,而另一些人则表现出较慢或短暂的变化;DXA证实了群体水平的增长,但BTMs并不反映个体CIM变化.
结论:
- 同位素标记物 (CIM) 显示出作为一种敏感的,个性化的生物标记物的潜力,用于监测骨质疏松症中登苏马布治疗反应.
- 与DXA和BTM等传统方法相比,CIM在检测骨动态的细微,患者特异性变化方面可能具有优势.
- 需要在更大的受控研究中进一步验证,以确定CIM在个性化骨质疏松症管理中的作用.
相关概念视频
¹³C NMR: Distortionless Enhancement by Polarization Transfer (DEPT)
When proton-coupled carbon-13 spectra are simplified by a broadband proton decoupling technique, structural information about the coupled protons is lost. Distortionless enhancement by polarization transfer (DEPT) is a technique that provides information on the number of hydrogens attached to each carbon in a molecule. While the DEPT experiment utilizes complex pulse sequences, the pulse delay and flip angle are specifically manipulated. The resulting signals have different phases depending on...
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Differential Staining Technique
Differential staining is an essential microbiological technique that exploits variations in cell wall structures to classify and identify microorganisms. It facilitates the distinction of bacteria, aiding in diagnostic and research applications. Two of the most widely used differential staining methods are Gram staining and acid-fast staining, both of which rely on the chemical and structural differences in bacterial cell walls.Gram Staining TechniqueGram staining differentiates bacteria by...


